, Volume 66, Issue 3, pp 585–595 | Cite as

miR-762 modulates thyroxine-induced cardiomyocyte hypertrophy by inhibiting Beclin-1

  • Zheng QiangEmail author
  • Beifang Jin
  • Yuntao Peng
  • Yan Zhang
  • Junfeng Wang
  • Chen Chen
  • Xinfeng Wang
  • Fang LiuEmail author
Original Article



Whether autophagy plays a key role in thyroxine-induced cardiomyocyte hypertrophy, and whether the role of autophagy in thyroxine-induced cardiomyocyte hypertrophy is related to targeting of Beclin-1 by miR-762 remains unclear. This research focused on testing these two hypotheses. Importantly, the results of this study will help us better understand the molecular mechanisms of thyroxine-induced cardiomyocyte hypertrophy.


In vivo and in vitro, RT-PCR, western blot, and dual luciferase reporter assay were performed to understand the molecular mechanism of thyroxine-induced cardiomyocyte hypertrophy. HE staining, Masson staining, transmission electron microscopy, and immunofluorescence were used to observe intuitively changes of hearts and cardiomyocytes.


Our results showed that in vivo, serum TT3, TT4, and heart rate were significantly upregulated in the T4 group compared with the control group. Moreover, the surface area of cardiomyocytes was significantly increased in the T4 group, and the structural disorder was accompanied by obvious hyperplasia of collagen fibers. The expression of ANP, and β-MHC was significantly upregulated in the T4 group. In addition, LC3 II/LC3 I, Beclin-1 and the count of autophagic vacuoles were significantly upregulated, but miR-762 was significantly downregulated in the T4 group compared to the control group. Subsequently, a dual luciferase reporter assay suggested that Beclin-1 was the target gene of miR-762. In vitro, the results for the T3 group were consistent with the results for the T4 group. Furthermore, cardiomyocyte hypertrophy and autophagic activity were attenuated in the T3 + miR-762 mimic group compared with the T3 group. In contrast, cardiomyocyte hypertrophy and autophagic activity were aggravated in the T3 + miR-762 inhibitor group compared with the T3 group.


miR-762 modulates thyroxine-induced cardiomyocyte hypertrophy by inhibiting Beclin-1.


miR-762 Beclin-1 Autophagy Thyroxine Cardiomyocyte hypertrophy 



The work was supported by the National Natural Science Foundation of China (81660046), the Guangxi Scholarship Fund of the Guangxi Education Department, and the Natural Science Foundation of Guangxi Province (2018GXNSFAA050096).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All animal protocols were approved by the review board of the Animal Care and Ethics Committee of Guilin Medical University.


  1. 1.
    R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr. Pract. 17(3), 456–520 (2011). CrossRefPubMedGoogle Scholar
  2. 2.
    D. Devereaux, S.Z. Tewelde, Hyperthyroidism and thyrotoxicosis. Emerg. Med. Clin. N. Am. 32(2), 277–292 (2014). CrossRefGoogle Scholar
  3. 3.
    A.P. Weetman, Graves’ disease. N. Engl. J. Med. 343(17), 1236–1248 (2000). CrossRefPubMedGoogle Scholar
  4. 4.
    A. Jabbar, A. Pingitore, S.H. Pearce, A. Zaman, Iervasi G., S. Razvi, Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14(1), 39–55 (2017). CrossRefPubMedGoogle Scholar
  5. 5.
    J. Yuan, H. Liu, W. Gao, L. Zhang, Y. Ye, L. Yuan, Z. Ding, J. Wu, L. Kang, X. Zhang, MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress. Theranostics 8(9), 2565–2582 (2018). CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    J.P. Wang, R.F. Chi, K. Wang, T. Ma, X.F. Guo, X.L. Zhang, B. Li, F.Z. Qin, X.B. Han, B.A. Fan, Oxidative stress impairs myocyte autophagy, resulting in myocyte hypertrophy. Exp. Physiol. 103(4), 461–472 (2018). CrossRefPubMedGoogle Scholar
  7. 7.
    D. Glick, S. Barth, K.F. Macleod, Autophagy: cellular and molecular mechanisms. J. Pathol. 221(1), 3–12 (2010). CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    S. Kaushik, U. Bandyopadhyay, S. Sridhar, R. Kiffin, M. Martinez-Vicente, M. Kon, S.J. Orenstein, E. Wong, A.M. Cuervo, Chaperone-mediated autophagy at a glance. J. Cell Sci. 124(4), 495–499 (2011). CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Shuhei Nakamura, Tamotsu Yoshimori, Autophagy and longevity. Mol. Cells 41(1), 65–72 (2018). CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Y.Y. Sun, S.S. Qin, Y.H. Cheng, C.Y. Wang, X.J. Liu, Y. Liu, X.L. Zhang, W. Zhang, J.X. Zhan, S. Shao, MicroRNA expression profile and functional analysis reveal their roles in contact inhibition and its disruption switch of rat vascular smooth muscle cells. Acta Pharmacol. Sin. 39(5), 885–892 (2018). CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    K. Liu, Q. Hao, J. Wei, G.H. Li, Y. Wu, Y.F. Zhao, MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A. J. Hypertens. 36(9), 1847–1857 (2018). CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    F. Tang, T.L. Yang, MicroRNA-126 alleviates endothelial cells injury in atherosclerosis by restoring autophagic flux via inhibiting of PI3K/Akt/mTOR pathway. Biochem. Biophys. Res. Commun. 495(1), 1482–1489 (2018). CrossRefPubMedGoogle Scholar
  13. 13.
    H. Liu, P. Liu, X. Shi, D. Yin, J. Zhao, NR4A2 protects cardiomyocytes against myocardial infarction injury by promoting autophagy. Cell Death Discov. 4, 27 (2018). CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Y. Li, Y. Wang, M. Zou, C. Chen, Y. Chen, R. Xue, Y. Dong, C. Liu, AMPK blunts chronic heart failure by inhibiting autophagy. Biosci. Rep. 38(4), BSR20170982 (2018). CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Q. Yao, X. Wang, W. He, Z. Song, B. Wang, J. Zhang, Q. Qin, Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves’ disease. Endocrine (2019). Scholar
  16. 16.
    H.H. Samuels, J.S. Tsai, J. Casanova, F. Stanley, Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells. J. Clin. Investig. 54(4), 853–865 (1974). CrossRefPubMedGoogle Scholar
  17. 17.
    P.J. Davis, F.B. Davis, S.A. Mousa, M.K. Luidens, H.Y. Lin, Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu. Rev. Pharmacol. Toxicol. 51, 99–115 (2011). CrossRefPubMedGoogle Scholar
  18. 18.
    W. Pan, Y. Zhong, C. Cheng, B. Liu, L. Wang, A. Li, L. Xiong, S. Liu, MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS ONE 8(1), e53950 (2013). 10.1371/journal.pone.0053950CrossRefGoogle Scholar
  19. 19.
    J. Huang, W. Sun, H. Huang, J. Ye, W. Pan, Y. Zhong, C. Cheng, X. You, B. Liu, L. Xiong, miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS ONE 9(4), e94382 (2014). 10.1371/journal.pone.0094382CrossRefGoogle Scholar
  20. 20.
    A.L. Li, J.B. Lv, L. Gao, MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy. Eur. Rev. Med. Pharmacol. Sci. 21(23), 5462–5470 (2017). CrossRefPubMedGoogle Scholar
  21. 21.
    Z. Li, Y. Song, L. Liu, N. Hou, X. An, D. Zhan, Y. Li, L. Zhou, P. Li, L. Yu, miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ. 24(7), 1205–1213 (2017). CrossRefPubMedGoogle Scholar
  22. 22.
    M. Su, J. Wang, C. Wang, X. Wang, W. Dong, W. Qiu, Y. Wang, X. Zhao, Y. Zou, L. Song, MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ. 22(6), 986–999 (2015). CrossRefPubMedGoogle Scholar
  23. 23.
    M. Su, Z. Chen, C. Wang, L. Song, Y. Zou, L. Zhang, R. Hui, J. Wang, Cardiac-specific overexpression of miR-222 induces heart failure and inhibits autophagy in mice. Cell Physiol. Biochem. 39(4), 1503–1511 (2016). CrossRefPubMedGoogle Scholar
  24. 24.
    M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, G.A. Calin, MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8(8), 467–477 (2011). CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    L. Zheng, C. Zhuang, X. Wang, L. Ming, Serum miR-146a, miR-155, and miR-210 as potential markers of Graves’ disease. J. Clin. Lab. Anal. 32(2) (2018). CrossRefGoogle Scholar
  26. 26.
    J. Wang, Y. Xiao, H. Zhang, Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves’ orbitopathy. Investig. Ophthalmol. Vis. Sci. 57(15), 6795 (2016). CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Zheng Qiang
    • 1
    Email author
  • Beifang Jin
    • 1
  • Yuntao Peng
    • 1
  • Yan Zhang
    • 1
  • Junfeng Wang
    • 1
  • Chen Chen
    • 1
  • Xinfeng Wang
    • 1
  • Fang Liu
    • 1
    • 2
    Email author
  1. 1.Department of AnatomyGuilin Medical UniversityGuilinChina
  2. 2.Center of Diabetic Systems Medicine, Guangxi Key Laboratory of ExcellenceGuilin Medical UniversityGuilinChina

Personalised recommendations